期刊文献+

氢质子磁共振波谱检测脑胶质瘤放疗后的放射性脑损伤 被引量:3

Detection of radiation brain injury of malignant glioma by ^1H-MRS
下载PDF
导出
摘要 目的:利用氢质子磁共振波谱(1 H-MRS)方法,探讨容积旋转调强(VMAT)技术与三维适形放射治疗(3DCRT)技术对脑胶质瘤术后患者行放射治疗后放射性脑损伤的差别。方法:24例经临床手术证实的恶性胶质瘤(WHOⅡ~Ⅳ级胶质瘤)术后患者,其中12例进行VMAT技术放疗,另外12例进行3DCRT技术放疗,处方剂量全部为DT60-66GY/30-33F,比较2组计划的剂量分布图,并运用1 H-MRS检查2组放疗前后感兴趣区(ROI)脑组织中N-乙酰天门冬氨酸(NAA)、肌酸(Cr)、胆碱(Cho)的代谢规律,计算NAA/Cr、Cho/Cr、NAA/Cho比值,比较各组数据。结果:VMAT组剂量分布明显优于3DCRT组,放疗后2组患者NAA/Cr比值较放疗前有所降低,2组治疗后NAA/Cr比值比较差异有统计学意义(P<0.01);放疗后2组患者Cho/Cr、NAA/Cho比值较放疗前有所增高,2组治疗后NAA/Cho比值比较差异有统计学意义(P<0.01)。结论:利用VMAT技术对脑胶质瘤术后患者进行放疗,较利用3DCTR技术放疗在减轻放射性脑损伤方面有一定优势。 Objective Using proton magnetic resonance spectroscopy(^1H-MRS) method,to evaluate the difference of radiation brain injury between volumetric modulated arc therapy(VMAT) and three-dimensional conformal radiation therapy(3DCRT) in patients with postoperative glioma after radiation therapy.Methods 24 patients with malignant glioma(WHOⅡ-Ⅳ grade glioma) confirmed with clinical surgery were selected,among them 12 patients were treated with VMAT technique,and another 12 patients with 3DCRT technique,all received DT60-66GY/30-33F dose prescriptions.1H-MRS examination was performed to analyze the change of metabolites in the brain tissues of region of interest(ROI) before and after radiotherapy,and the ratios of NAA/ Cr,Cho / Cr,NAA / Cho were computed.Results The dose distribution of VMAT group was superior to 3DCRT group,the NAA/Cr in two groups after radiation were decreased compared with before radiation,there was a statistically difference in NAA/Cr after radiation between two groups(P〈0.01).The Cho / Cr and NAA / Cho in two groups were increased compared with before radiation;after radiation,only NAA/Cho had a statistical difference between two groups(P〈0.01).Conclusion VMAT technique is superior to 3DCTR to reduce radiation brain injury in patients with postoperative glioma.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2011年第4期742-745,F0003,共5页 Journal of Jilin University:Medicine Edition
基金 吉林省自然科学基金资助课题(201015235)
关键词 容积旋转调强 三维适形放射治疗 氢质子磁共振波谱 脑胶质瘤 volumetric modulated arc therapy~ three-dimensional conformal radiation therapy magnetic resonancespectroseopy malignant glioma
  • 相关文献

参考文献11

  • 1Patrick YW, Kesaris S. Malignant gliomas in adults [J]. N EnglJ Med, 2008, 359 (8): 492-507.
  • 2Buatti J, Ryken TC, Smith MC, et al. Radiation therapy of pathologically conf.irmed newly diagnosed glioblastoma in adults [J]. J Neurooncol, 2008, 89 (3): 313 -337.
  • 3刘雅洁,蔡伟明.鼻咽癌放疗后放射性脑损伤研究进展[J].中华放射医学与防护杂志,2001,21(1):67-68. 被引量:13
  • 4Alba AB, Alicia T, Enrico F, et al. Glioblastoma in adults [J]. Crit Rev Oncol Hematol, 2008, 67 (2) : 139 -152.
  • 5Chan JL, patterns conformal Lee SW, Fraass BA, et al. Survival and failure of high-grade gliomas radiotherapy[J]. J Clin after three dimensiona Oncol, 2002, 20 (1):1635-1642.
  • 6Tanaka M, lno Y, Nakagawa K, et al. High dose conformal radiotherapy for supratentorial malignant glioma: a historical comparison[J]. Lancet, 2005, 6 (12): 953- 960.
  • 7Lee N, Xia P, Fischbein NJ, et al. Intensity modulated radiation therapy for head-and neck cancer: the UCSF experience focusing on target volume delineation [J]. Int J Radial Oncol Biol Phys, 2003, 57 (1): 49 -60.
  • 8Narayana A, Yamada J, Berry S, et al. lmensity modulated radiotherapy in high grade gliomas; clinical and dosimetric results [J]. Int J Radiat Oncol Biol Phys, 2006, 64 (3): 892 -897.
  • 9王琨华,范国光,苏惠群,陈丽英,刘兆玉,郭启勇.在体脑胶质瘤的氢质子磁共振波谱分析[J].中国临床医学影像杂志,2002,13(3):157-160. 被引量:6
  • 10王秋实,刘辉,梁长虹.33例活体肝脏磁共振氢质子波谱分析[J].山东医药,2007,47(23):67-68. 被引量:12

二级参考文献16

  • 1张雪林,蒋猛,邱士军,张玉忠,文戈.鼻咽癌放疗后放射性脑病的^1H-MR波谱研究[J].中华放射学杂志,2004,38(6):570-574. 被引量:18
  • 2张雪林,阎卫平,邹常敬,刘中宇,刘杏元,黄其鎏.鼻咽癌放疗后放射性脑病的MRI诊断[J].中华放射学杂志,1995,29(10):658-662. 被引量:29
  • 3王霄英,周良平,李飞宇,丁建平,山刚志,蒋学祥.前列腺癌的MR波谱特征与Gleason评分的关系[J].中华放射学杂志,2006,40(11):1181-1184. 被引量:28
  • 4Vermathen P,Capizzano AA,Maudsley AA.Administration and 1 HMRS detection of histidine in human brain:application to in vivo pH measurement.Magn Reson Med,2000,43:665-675.
  • 5Howe FA,Opstad KS.1H-MR spectroscopy of brain tumours and masses (Review).NMR Biomed,2003,16:123-131.
  • 6Vikhoff-Baaz B,Malmgren K,Jonsson L,et al.Lateradiation with magnetic resonance spectroscopic imaging in temporal lobe epilepsy:an evaluation of visual and region of interest analysis of metabolite concentration images.Neuroadiology,2001,43:721-727.
  • 7Chan YL,Leung SF,King AD,et al,Late radiation injury to the temporal lobes:morphologic evaluation at MR imaging.Radiology,1999,213:800-807.
  • 8方虹,郭庆林,赵海涛,张贵祥,俞高龙,葛芳杰.脑肿瘤^1H磁共振波谱改变[J].中华放射学杂志,1997,31(3):203-205. 被引量:9
  • 9Murphy M,Loosemore A,Clifton AG,et al.The contribution of proton magnetic resonance spectroscopy (1H MRS) to clinical brain tumor diagnosis[J].Br J Neurosurg,2002,16(5):329-334.
  • 10Yeung DK,Yang WT,Tse GM.Human breast cancer:in vivo proton MR spectroscopy in the characterization of histopathological subtypes and preliminary observations in axillary node metastases[J].Radiology,2002,225(1):190-197.

共引文献56

同被引文献39

  • 1蒋马伟,周仁华,姚原,林青,夏士安,吴国华.脑胶质瘤放疗靶区确定的方法学研究[J].中华肿瘤防治杂志,2007,14(13):997-999. 被引量:8
  • 2杨冬,王忠诚,邱晓光,江涛,张亚卓.放、化疗同步治疗高级别胶质瘤[J].中华神经外科疾病研究杂志,2007,6(5):450-453. 被引量:20
  • 3谷铣之,殷蔚伯,余子豪,等.肿瘤放射治疗学[M].4版北京:中国协和医科大学出版社,2007:1122-1125.
  • 4Stupp R, Masn WP, van den Bent MJ, et al. Radiontherapy plus concomitant and adjuvant temozolomide for glioblastoma[J]. NEngIJ Med, 2005, 352(10): 987 -996.
  • 5Iuchi T, Hatano K, Narita Y, et al. Hypofractionated high- dose irradiation for the treatment of malignant astrocytomas using simultaneous integrated boost technique by IMRT[J]. Int J Radiat Oneol Biol Phys, 2006, 64(5) : 1317-1324.
  • 6CorsaP, Pafisi S, Raguso A, et al. Temozolimide and radiotherapy as first-line treatment of high'grade gliomas[J]. Tumor, 2006, 92(4): 299- 305.
  • 7van Rin J, Heimans JJ, van den Berg J, et al. Survival of human glioma cells treated with various combination of temozolomide and X-rays[J]. Int J Radiat Oncol Biol Phys,2000, 47(3): 779-784.
  • 8Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase study: 5-year analysis of the EORTC- NCIC trial[J]. Lancet Oncol, 2009, 10(5) : 459-466.
  • 9Papuashvili GS, Gagua RO, Ninua NG. Temozolomide-a new antitumor preparation in the treatment of central nervous system malignant tumors [J]. Georgian Med News, 2006(134), 31-34.
  • 10Moller-Hartmann W,Herminghaus S,Krings T. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions[J].Neuroradiology,2002,(05):371-381.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部